1. FRI0034 Adalimumab reduces CXCR4 expression during inflammatory arthritis and in fibroblast-like synoviocytes and osteoclasts under chronic TNF exposure. (15th June 2017) Authors: Harvey, BP; Li, L; Konrad, M; Knight, H; Westmoreland, S; Ruzek, M; Kaymakcalan, Z Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗